Published in Foot Ankle Int on October 01, 2006
Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand. Diabetologia (2008) 1.43
An overview of the Charcot foot pathophysiology. Diabet Foot Ankle (2013) 0.97
Inpatient management of diabetic foot disorders: a clinical guide. Diabetes Care (2013) 0.95
The pathogenesis of Charcot neuroarthropathy: current concepts. Diabet Foot Ankle (2012) 0.83
Circulating monocytes: an appropriate model for bone-related study. Osteoporos Int (2015) 0.83
Hyperglycemia induced and intrinsic alterations in type 2 diabetes-derived osteoclast function. Oral Dis (2013) 0.82
Charcot foot reconstruction with combined internal and external fixation: case report. J Orthop Surg Res (2010) 0.78
Inhibition of TNF-α Reverses the Pathological Resorption Pit Profile of Osteoclasts from Patients with Acute Charcot Osteoarthropathy. J Diabetes Res (2015) 0.77
The effect of zoledronic acid on the clinical resolution of Charcot neuroarthropathy: a pilot randomized controlled trial. Diabetes Care (2011) 0.77
Neuropathy and the vascular-bone axis in diabetes: lessons from Charcot osteoarthropathy. Osteoporos Int (2013) 0.76
Classifications in brief: Eichenholtz classification of Charcot arthropathy. Clin Orthop Relat Res (2014) 0.75
Expression of the receptor activator of nuclear factor-kB ligand in peripheral blood mononuclear cells in patients with acute Charcot neuroarthropathy. Int J Med Sci (2016) 0.75
Pathogenesis and potential relative risk factors of diabetic neuropathic osteoarthropathy. J Orthop Surg Res (2017) 0.75
Activation of beta-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult beta-catenin conditional activation mice. J Bone Miner Res (2009) 3.61
Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest (2002) 3.29
2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis (2012) 3.22
Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene. Gene (2006) 2.16
Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med (2005) 2.10
Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J Bone Miner Res (2005) 2.04
Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase. Genesis (2007) 2.01
Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice. Arthritis Rheum (2004) 1.94
The biology of the growth plate. J Bone Joint Surg Am (2003) 1.89
COX-1 and COX-2 expression in osteoid osteomas. J Orthop Res (2002) 1.84
RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis. J Bone Miner Res (2004) 1.83
Inhibition of beta-catenin signaling in articular chondrocytes results in articular cartilage destruction. Arthritis Rheum (2008) 1.77
RBPjkappa-dependent Notch signaling regulates mesenchymal progenitor cell proliferation and differentiation during skeletal development. Development (2010) 1.72
Conditional activation of β-catenin signaling in mice leads to severe defects in intervertebral disc tissue. Arthritis Rheum (2012) 1.67
Inhibition of beta-catenin signaling causes defects in postnatal cartilage development. J Cell Sci (2008) 1.67
ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development. J Bone Miner Res (2003) 1.66
A perspective: engineering periosteum for structural bone graft healing. Clin Orthop Relat Res (2008) 1.57
Rigidity comparison of locking plate and intramedullary fixation for tibiotalocalcaneal arthrodesis. Foot Ankle Int (2008) 1.55
Regulation of chondrogenesis and chondrocyte differentiation by stress. J Clin Invest (2008) 1.53
Biological effects of rAAV-caAlk2 coating on structural allograft healing. Mol Ther (2005) 1.49
Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. J Cell Physiol (2006) 1.46
Cyclin D1-cdk4 induce runx2 ubiquitination and degradation. J Biol Chem (2006) 1.45
BMP2, but not BMP4, is crucial for chondrocyte proliferation and maturation during endochondral bone development. J Cell Sci (2011) 1.44
NOTCH signaling in skeletal progenitors is critical for fracture repair. J Clin Invest (2016) 1.41
Structural bone allograft combined with genetically engineered mesenchymal stem cells as a novel platform for bone tissue engineering. Tissue Eng (2007) 1.41
Smad3-deficient chondrocytes have enhanced BMP signaling and accelerated differentiation. J Bone Miner Res (2005) 1.39
The orthopaedic genome: what does the future hold and are we ready? J Bone Joint Surg Am (2002) 1.39
Induction of an osteoarthritis-like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice. Arthritis Rheum (2008) 1.31
Reduced COX-2 expression in aged mice is associated with impaired fracture healing. J Bone Miner Res (2009) 1.31
TNF-alpha and pathologic bone resorption. Keio J Med (2005) 1.31
NFkappaB: a pivotal transcription factor in prostate cancer metastasis to bone. Clin Orthop Relat Res (2003) 1.30
Axin2 controls bone remodeling through the beta-catenin-BMP signaling pathway in adult mice. J Cell Sci (2009) 1.29
Quantitative mouse model of implant-associated osteomyelitis and the kinetics of microbial growth, osteolysis, and humoral immunity. J Orthop Res (2008) 1.28
Cartilage-specific RBPjκ-dependent and -independent Notch signals regulate cartilage and bone development. Development (2012) 1.28
Osterix/Sp7 regulates mesenchymal stem cell mediated endochondral ossification. J Cell Physiol (2008) 1.27
Proinflammatory cytokines and metalloproteases are expressed in the subacromial bursa in patients with rotator cuff disease. Arthroscopy (2005) 1.27
Adhesions in a murine flexor tendon graft model: autograft versus allograft reconstruction. J Orthop Res (2008) 1.25
Runx1/AML1/Cbfa2 mediates onset of mesenchymal cell differentiation toward chondrogenesis. J Bone Miner Res (2005) 1.24
Articular cartilage biology. J Am Acad Orthop Surg (2003) 1.22
Runx2/Cbfa1 stimulation by retinoic acid is potentiated by BMP2 signaling through interaction with Smad1 on the collagen X promoter in chondrocytes. J Cell Biochem (2003) 1.20
Rescue of impaired fracture healing in COX-2-/- mice via activation of prostaglandin E2 receptor subtype 4. Am J Pathol (2009) 1.20
Physiology and pathophysiology of the growth plate. Birth Defects Res C Embryo Today (2003) 1.20
Overlapping expression of Runx1(Cbfa2) and Runx2(Cbfa1) transcription factors supports cooperative induction of skeletal development. J Cell Physiol (2005) 1.20
Use of volumetric computerized tomography as a primary outcome measure to evaluate drug efficacy in the prevention of peri-prosthetic osteolysis: a 1-year clinical pilot of etanercept vs. placebo. J Orthop Res (2003) 1.19
Wnt-mediated regulation of chondrocyte maturation: modulation by TGF-beta. J Cell Biochem (2005) 1.18
In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells. Blood (2009) 1.18
Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy. Biochem Biophys Res Commun (2013) 1.18
Volumetric computerized tomography as a measurement of periprosthetic acetabular osteolysis and its correlation with wear. Arthritis Res (2001) 1.18
In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. J Bone Miner Res (2002) 1.17
Freeze-dried tendon allografts as tissue-engineering scaffolds for Gdf5 gene delivery. Mol Ther (2008) 1.17
Transforming growth factor-beta stimulates cyclin D1 expression through activation of beta-catenin signaling in chondrocytes. J Biol Chem (2006) 1.17
Bone morphogenetic protein 2 activates Smad6 gene transcription through bone-specific transcription factor Runx2. J Biol Chem (2007) 1.17
Teriparatide (1-34 human PTH) regulation of osterix during fracture repair. J Cell Biochem (2008) 1.16
Cartilage-specific β-catenin signaling regulates chondrocyte maturation, generation of ossification centers, and perichondrial bone formation during skeletal development. J Bone Miner Res (2012) 1.15
Remodeling of murine intrasynovial tendon adhesions following injury: MMP and neotendon gene expression. J Orthop Res (2009) 1.14
Complications of ankle fracture in patients with diabetes. J Am Acad Orthop Surg (2008) 1.13
A role for the BMP antagonist chordin in endochondral ossification. J Bone Miner Res (2002) 1.13
Current topics review: Charcot neuroarthropathy of the foot and ankle. Foot Ankle Int (2005) 1.12
Treatment of osteochondral lesions of the talus with particulated juvenile cartilage. Foot Ankle Int (2013) 1.12
Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis. Sci Transl Med (2011) 1.12
Lead exposure inhibits fracture healing and is associated with increased chondrogenesis, delay in cartilage mineralization, and a decrease in osteoprogenitor frequency. Environ Health Perspect (2005) 1.11
PTH-enhanced structural allograft healing is associated with decreased angiopoietin-2-mediated arteriogenesis, mast cell accumulation, and fibrosis. J Bone Miner Res (2013) 1.11
Self-complementary AAV2.5-BMP2-coated femoral allografts mediated superior bone healing versus live autografts in mice with equivalent biomechanics to unfractured femur. Mol Ther (2011) 1.10
Thrombospondin-2 influences the proportion of cartilage and bone during fracture healing. J Bone Miner Res (2009) 1.10
Effects of receptor activator of NFkappaB (RANK) signaling blockade on fracture healing. J Orthop Res (2003) 1.10
PGE2 inhibits chondrocyte differentiation through PKA and PKC signaling. Exp Cell Res (2004) 1.09
TAK1 regulates cartilage and joint development via the MAPK and BMP signaling pathways. J Bone Miner Res (2010) 1.08
TGF-beta signaling in chondrocytes. Front Biosci (2005) 1.08
Parathyroid hormone-related peptide (PTHrP) inhibits Runx2 expression through the PKA signaling pathway. Exp Cell Res (2004) 1.08
Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Joint Surg Am (2002) 1.07
Impact of Smad3 loss of function on scarring and adhesion formation during tendon healing. J Orthop Res (2010) 1.07
COX-2 from the injury milieu is critical for the initiation of periosteal progenitor cell mediated bone healing. Bone (2008) 1.07
Forum on bone and skeletal muscle interactions: summary of the proceedings of an ASBMR workshop. J Bone Miner Res (2013) 1.06
A phage display technique identifies a novel regulator of cell differentiation. J Biol Chem (2002) 1.06
Exposure to receptor-activator of NFkappaB ligand renders pre-osteoclasts resistant to IFN-gamma by inducing terminal differentiation. Arthritis Res Ther (2002) 1.06
Runx3/AML2/Cbfa3 regulates early and late chondrocyte differentiation. J Bone Miner Res (2007) 1.05
Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. J Orthop Res (2002) 1.05
Fibroblasts express RANKL and support osteoclastogenesis in a COX-2-dependent manner after stimulation with titanium particles. J Bone Miner Res (2005) 1.04
Health-related quality of life for patients with rheumatoid arthritis foot involvement. Foot Ankle Int (2004) 1.03
Transforming growth factor-beta and Wnt signals regulate chondrocyte differentiation through Twist1 in a stage-specific manner. Mol Endocrinol (2007) 1.03
Short-term and long-term orthopaedic issues in patients with fragility fractures. Clin Orthop Relat Res (2011) 1.03
Differential effects of biologic versus bisphosphonate inhibition of wear debris-induced osteolysis assessed by longitudinal micro-CT. J Orthop Res (2008) 1.02
Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFkappaB. Exp Cell Res (2005) 1.01
muCT-based measurement of cortical bone graft-to-host union. J Bone Miner Res (2009) 1.01
Evaluation of dense polylactic acid/beta-tricalcium phosphate scaffolds for bone tissue engineering. J Biomed Mater Res A (2010) 1.01
Teriparatide therapy enhances devitalized femoral allograft osseointegration and biomechanics in a murine model. Bone (2010) 1.00
Smurf2 induces degradation of GSK-3beta and upregulates beta-catenin in chondrocytes: a potential mechanism for Smurf2-induced degeneration of articular cartilage. Exp Cell Res (2009) 0.99
Fixation of calcaneal avulsion fractures using screws with and without suture anchors: a biomechanical investigation. Foot Ankle Int (2007) 0.99
Treatment of stage II posterior tibial tendon deficiency with flexor digitorum longus tendon transfer and calcaneal osteotomy. Foot Ankle Int (2004) 0.99
Beta-catenin, cartilage, and osteoarthritis. Ann N Y Acad Sci (2010) 0.99
Autoimmunity and bone. Ann N Y Acad Sci (2006) 0.98
ATF-2 cooperates with Smad3 to mediate TGF-beta effects on chondrocyte maturation. Exp Cell Res (2003) 0.97
Recent advances in gene delivery for structural bone allografts. Tissue Eng (2007) 0.97
Axin2 regulates chondrocyte maturation and axial skeletal development. J Orthop Res (2010) 0.97
Axin1 and Axin2 are regulated by TGF- and mediate cross-talk between TGF- and Wnt signaling pathways. Ann N Y Acad Sci (2007) 0.97
Efficacy of colistin-impregnated beads to prevent multidrug-resistant A. baumannii implant-associated osteomyelitis. J Orthop Res (2009) 0.96
Mechanical comparison of cyclic loading in five different first metatarsal shaft osteotomies. Foot Ankle Int (2002) 0.96
Assessment and management of the orthopedic and other complications of Proteus syndrome. J Child Orthop (2011) 0.96
Retinoic acid stimulates chondrocyte differentiation and enhances bone morphogenetic protein effects through induction of Smad1 and Smad5. Endocrinology (2003) 0.95